阿诺医药(ANL)
盘后7.980.000.00%16:10 EDT
7.98+0.03+0.38%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称阿诺医药所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况作为一家临床阶段的全球性生物制药公司，阿诺医药秉承“将癌症变成一种慢性疾病乃至治愈”的使命，致力于成为打造“全球新”肿瘤药物的创新型研发企业，以更优良的治疗方式惠及中国乃至全球患者。2016年阿诺医药改制成立于中国杭州，在中美两地均设有研发及临床运营中心。 阿诺医药集结了世界一流的领导和研发团队、独特的药物开发技术平台，并与多家全球制药企业开展合作。通过“联合创新”及“自主研发”的模式已打造了多个全球化的产品管线，目前涵盖10余种抗肿瘤候选药物。- 2025-09-16Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-05-10Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend][修订]年度报告Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2025-05-01Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]年度报告Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2025-02-14Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend][修订]年度报告Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2025-01-27Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-01-02Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2024-05-13Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2024-04-19Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]年度报告Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-03-04Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-02-15Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-02-15Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-02-15Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-01-31Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-13Form SC 13G - Statement of acquisition of beneficial ownership by individuals超过5%披露Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-09-27Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
8.16
今开
8.12
量比
1.58
最低
7.22
昨收
7.95
换手率
0.70%